文献速递瓣膜外科

左侧感染性心内膜炎:手术与药物治疗的疗效比较

Efficacy of Primary Surgical Versus Medical Intervention for Treatment of Left-Sided Infective Endocarditis.
PubMed 文献 · Ann Thorac Surg · 2020-04-18

该回顾性研究纳入1998至2014年左侧葡萄球菌、链球菌或肠球菌感染性心内膜炎患者,比较瓣膜置换手术与单纯抗生素治疗的结局。手术组30天死亡率更低(7% vs 16%,P<.001),1年生存获益(HR 0.48,95%CI 0.36-0.64),但脓毒症休克和肾功能不全发生率更高。

要点

  • 手术组30天死亡率显著低于药物组(7% vs 16%,P<.001)。
  • 手术组1年生存获益显著(HR 0.48,95%CI 0.36-0.64)。
  • 手术组脓毒症休克和肾功能不全发生率更高。

核心结论

  • 与药物治疗相比,左侧葡萄球菌、链球菌或肠球菌感染性心内膜炎患者行瓣膜置换手术在30天和1年均有生存优势。

研究设计与样本

  • 回顾性研究,纳入1998至2014年单中心左侧葡萄球菌、链球菌或肠球菌感染性心内膜炎患者,手术组245例,药物组164例。
  • 使用倾向评分逆概率治疗加权平衡两组临床危险因素、STS评分和病原体。

主要发现

  • 30天死亡率药物组高于手术组(全队列7% vs 16%,P<.001;葡萄球菌亚组7% vs 22%,P<.001)。
  • 手术组脓毒症休克和肾功能不全发生率更高,但30天卒中和栓塞事件两组无差异。
  • Cox生存分析显示手术治疗的1年生存获益HR为0.48(95%CI 0.36-0.64),且不受病原体影响。

临床怎么用

  • 对于左侧葡萄球菌、链球菌或肠球菌感染性心内膜炎,瓣膜置换手术可能带来生存获益,需权衡术后脓毒症休克和肾功能不全风险。

局限性

  • 回顾性单中心研究,可能存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Left-sided staphylococcal, streptococcal, and enterococcal infective endocarditis (IE) is associated with poor clinical outcomes. Our primary aim is to compare clinical outcomes of staphylococcal, streptococcal, and enterococcal IE patients who undergo valve replacement surgery and outcomes of patients who are treated solely with antibiotics. METHODS: All patients were treated medically or surgically for left-sided staphylococcal, streptococcal, or enterococcal IE at our institution from 1998 to 2014 and were retrospectively studied. The primary outcome of interest was 30-day and 1-year mortality, and secondary outcomes included posttreatment septic shock, embolic events, stroke, and end-stage renal disease at 30 days. Inverse probability treatment weights, derived from propensity scores, were used to balance the medical and surgical cohorts across clinical risk factors, The Society of Thoracic Surgeon scores, and pathogens. Outcomes were compared comprehensively and in a staphylococcal-only subanalysis. RESULTS: Study population consisted of 245 surgical patients and 164 medical patients. Mortality at 30 days was higher in the medical cohort, both in aggregate and for staphylococcal only (all, 7% vs 16%, P < .001; staphylococcal only, 7% vs 22%, P < .001). Surgical patients had a higher incidence of septic shock and renal dysfunction; however, stroke and embolic events at 30 days were not different between cohorts. Cox survival analysis demonstrated that surgical treatment provided a 1-year survival benefit, with a hazard ratio of 0.48 (95% confidence interval, 0.36 to 0.64) that was robust regardless of pathogen. CONCLUSIONS: Compared with medical management, valve replacement surgery in patients with left-sided staphylococcal, streptococcal, or enterococcal IE appears to confer a survival advantage at 30 days and 1 year.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Gatzoflias S, Beier MA, Ning Y, et al. Efficacy of Primary Surgical Versus Medical Intervention for Treatment of Left-Sided Infective Endocarditis. Ann Thorac Surg. 2020. PMID: 32315643. doi:10.1016/j.athoracsur.2020.03.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。